Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Despite the widespread clinical use of dynamic susceptibility contrast (DSC) MRI, DSC-MRI methodology has not been standardized, hindering its utilization for response assessment in multicenter trials. Recently, the DSC-MRI Standardization Subcommittee of the Jumpstarting Brain Tumor Drug Developmen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Boxerman, Jerrold L, Quarles, Chad C, Hu, Leland S, Erickson, Bradley J, Gerstner, Elizabeth R, Smits, Marion, Kaufmann, Timothy J, Barboriak, Daniel P, Huang, Raymond H, Wick, Wolfgang, Weller, Michael, Galanis, Evanthia, Kalpathy-Cramer, Jayashree, Shankar, Lalitha, Jacobs, Paula, Chung, Caroline, van den Bent, Martin J, Chang, Susan, Al Yung, W K, Cloughesy, Timothy F, Wen, Patrick Y, Gilbert, Mark R, Rosen, Bruce R, Ellingson, Benjamin M, Schmainda, Kathleen M
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523451/
https://ncbi.nlm.nih.gov/pubmed/32516388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa141
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares